Mark Eisner

EVP and Chief Medical Officer, Vir Biotechnology, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Feb 25, 2026

Companies

Vir Biotechnology, Inc.EVP and Chief Medical Officer −$0.0M

Trades

VIR Sold 1,889 shares at $9.82 · planned $0.0M Feb 25

VIR Sold 1,616 shares at $9.53 · planned $0.0M Feb 24

VIR Sold 2,089 shares at $7.45 · planned $0.0M Feb 23

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.